Study in Pediatric Volunteers of a Handheld Device Versus a Standard Diagnostic Device in Ophthalmic Refraction

Exclusion Criteria

• •Spherical correction \> +8 or \< -10
• •Using anticholinergic medications (including first-generation antihistamines) or other medications known to affect visual acuity within the greater of 3 days or 5 half-lives prior to enrolling in this study.
• •Using an investigational drug or approved therapy for investigational use within the greater of 3 days or 5 half-lives prior to enrolling in this study.
• •Has initiated any new medication in the past 2 weeks that, in the best medical judgment of the investigator, would impact their participation in the study or ability to use the EyeQue EQ103 device,
• •Any self/caregiver-reported mental illness or condition of the subject, including but not limited to claustrophobia, fear of simulators, nyctophobia.
• •Any self/caregiver-reported neurological diseases of the subject, including but not limited to: epilepsy, nystagmus.
• •Any self/caregiver-reported glaucoma diagnosis of the subject.
• •Eye disease, including but not limited to:
• •* Cataracts
• •* Macular degeneration
• •* Eye infection (by self-report or observation)
• •* Keratoconus
• •* Diabetic neuropathy/retinopathy
• •* Cytomegalovirus retinitis
• •* Color blindness (any color deficiency)
• •* Diabetic macular edema
• •* Amblyopia
• •* Chronic or acute uveitis
• •* Strabismus
• •* Astigmatism \> 3 diopters
• •* Macular hole
• •Lack physical dexterity to properly operate the EyeQue device.
• •Lack the ability to follow instruction.
• •Lack binocular vision.
• •Are colorblind.
• •Had eye surgery within the last 12 months.